FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1993638752> ?p ?o ?g. }

• W1993638752 endingPage "276" @default.
• W1993638752 startingPage "265" @default.
• W1993638752 abstract "The newly synthesized calcium channel blocker, Ro44-5912, significantly potentiates doxorubicin (Dox)-induced cytotoxicity at non-cytotoxic concentrations in Dox-resistant human ovarian cell line, A2780/DX5, overexpressing P170-glycoprotein (Pgp). Induction of DNA single- and double-strand breaks (ssbs and dsbs) was measured using alkaline elution and constant-field gel electrophoresis (CFGE) assays. The results indicate that potentiation of the cytotoxicity of Dox by Ro44-5912 was accompanied by significant increases in both, Dox-induced DNA ssbs and dsbs in the resistant cells. Pulsed-field gel electrophoresis (PFGE) analysis showed that Dox induced DNA fragments in the 50–800 kilobase (kb) and 0.8–5.7 megabase (Mb) ranges. The majority of the newly synthesized DNA fragments were in the 50–800 kb range. Ro44-5912 treatment resulted in significant potentiation of DNA fragmentation in the 50–800 kb range with a minor increase in 0.8–5.7 Mb DNA fragments, suggesting that the modulator functions by potentiating nascent DNA fragmentation in the resistant cells. Exposure to Dox with Ro44-5912 was associated with a prolonged blockage of cells in the S-phase. In contrast, exposure to Dox alone resulted in temporary blockage of cells in G2/M phase (∼24 h) followed by restoration of cell proliferation and normal DNA histograms at 48 h after 2 h drug exposure. Incorporation of BrdUrd by flow cytometric analysis was inhibited by Dox in the presence of Ro44-5912, showing that there is a block of DNA replication. An increased damage in newly synthesized DNA could concur with a blocked DNA replication. Moreover, slowing progression through the S-phase in cells exposed to Dox in combination with Ro44-5912 is accompanied by increased sensitivity of Dox poisons, indicating a correlation of specific S-phase perturbation with the reversal of Dox resistance by Ro44-5912 in cells expressing Pgp. The results suggest that drug-induced augmentation of nascent DNA fragmentation and specific cell-cycle perturbation are potentially important molecular determinants for reversal of multidrug resistance in addition to restoration of intracellular drug retention." @default.
• W1993638752 created "2016-06-24" @default.
• W1993638752 creator A5003033577 @default.
• W1993638752 creator A5023767824 @default.
• W1993638752 creator A5027809681 @default.
• W1993638752 creator A5041346764 @default.
• W1993638752 creator A5045095134 @default.
• W1993638752 creator A5059830806 @default.
• W1993638752 creator A5062349926 @default.
• W1993638752 creator A5076225093 @default.
• W1993638752 creator A5084999115 @default.
• W1993638752 date "1998-03-01" @default.
• W1993638752 modified "2023-10-17" @default.
• W1993638752 title "Novel cellular determinants for reversal of multidrug resistance in cells expressing P170-glycoprotein" @default.
• W1993638752 cites W1029507972 @default.
• W1993638752 cites W1544564404 @default.
• W1993638752 cites W1871801777 @default.
• W1993638752 cites W1964658039 @default.
• W1993638752 cites W1975497932 @default.
• W1993638752 cites W2012306261 @default.
• W1993638752 cites W2013404388 @default.
• W1993638752 cites W2015446431 @default.
• W1993638752 cites W2037707111 @default.
• W1993638752 cites W2043548659 @default.
• W1993638752 cites W2051129634 @default.
• W1993638752 cites W2053374394 @default.
• W1993638752 cites W2057609259 @default.
• W1993638752 cites W2068834948 @default.
• W1993638752 cites W2070134424 @default.
• W1993638752 cites W2086430589 @default.
• W1993638752 cites W2097878215 @default.
• W1993638752 cites W2102345056 @default.
• W1993638752 cites W2109689528 @default.
• W1993638752 cites W2118234018 @default.
• W1993638752 cites W2168070336 @default.
• W1993638752 cites W572492997 @default.
• W1993638752 doi "https://doi.org/10.1016/s0167-4889(97)00137-7" @default.
• W1993638752 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9540817" @default.
• W1993638752 hasPublicationYear "1998" @default.
• W1993638752 type Work @default.
• W1993638752 sameAs 1993638752 @default.
• W1993638752 citedByCount "6" @default.
• W1993638752 crossrefType "journal-article" @default.
• W1993638752 hasAuthorship W1993638752A5003033577 @default.
• W1993638752 hasAuthorship W1993638752A5023767824 @default.
• W1993638752 hasAuthorship W1993638752A5027809681 @default.
• W1993638752 hasAuthorship W1993638752A5041346764 @default.
• W1993638752 hasAuthorship W1993638752A5045095134 @default.
• W1993638752 hasAuthorship W1993638752A5059830806 @default.
• W1993638752 hasAuthorship W1993638752A5062349926 @default.
• W1993638752 hasAuthorship W1993638752A5076225093 @default.
• W1993638752 hasAuthorship W1993638752A5084999115 @default.
• W1993638752 hasBestOaLocation W19936387521 @default.
• W1993638752 hasConcept C109316439 @default.
• W1993638752 hasConcept C116084860 @default.
• W1993638752 hasConcept C143425029 @default.
• W1993638752 hasConcept C153911025 @default.
• W1993638752 hasConcept C185592680 @default.
• W1993638752 hasConcept C18903297 @default.
• W1993638752 hasConcept C190283241 @default.
• W1993638752 hasConcept C191015642 @default.
• W1993638752 hasConcept C202751555 @default.
• W1993638752 hasConcept C2776694085 @default.
• W1993638752 hasConcept C2781303535 @default.
• W1993638752 hasConcept C31573885 @default.
• W1993638752 hasConcept C43759708 @default.
• W1993638752 hasConcept C54355233 @default.
• W1993638752 hasConcept C552990157 @default.
• W1993638752 hasConcept C55493867 @default.
• W1993638752 hasConcept C86803240 @default.
• W1993638752 hasConceptScore W1993638752C109316439 @default.
• W1993638752 hasConceptScore W1993638752C116084860 @default.
• W1993638752 hasConceptScore W1993638752C143425029 @default.
• W1993638752 hasConceptScore W1993638752C153911025 @default.
• W1993638752 hasConceptScore W1993638752C185592680 @default.
• W1993638752 hasConceptScore W1993638752C18903297 @default.
• W1993638752 hasConceptScore W1993638752C190283241 @default.
• W1993638752 hasConceptScore W1993638752C191015642 @default.
• W1993638752 hasConceptScore W1993638752C202751555 @default.
• W1993638752 hasConceptScore W1993638752C2776694085 @default.
• W1993638752 hasConceptScore W1993638752C2781303535 @default.
• W1993638752 hasConceptScore W1993638752C31573885 @default.
• W1993638752 hasConceptScore W1993638752C43759708 @default.
• W1993638752 hasConceptScore W1993638752C54355233 @default.
• W1993638752 hasConceptScore W1993638752C552990157 @default.
• W1993638752 hasConceptScore W1993638752C55493867 @default.
• W1993638752 hasConceptScore W1993638752C86803240 @default.
• W1993638752 hasIssue "3" @default.
• W1993638752 hasLocation W19936387521 @default.
• W1993638752 hasLocation W19936387522 @default.
• W1993638752 hasOpenAccess W1993638752 @default.
• W1993638752 hasPrimaryLocation W19936387521 @default.
• W1993638752 hasRelatedWork W2017524522 @default.
• W1993638752 hasRelatedWork W2301571926 @default.
• W1993638752 hasRelatedWork W2356429962 @default.
• W1993638752 hasRelatedWork W2360805429 @default.
• W1993638752 hasRelatedWork W3003663993 @default.
• W1993638752 hasRelatedWork W4226330015 @default.

• next